About
Catherine Owen Adams has served on Agios's board since June 2023 and has been chief executive officer and a director of Acadia Pharmaceuticals since September 2024.
She was previously senior vice president, major markets at Bristol-Myers Squibb, overseeing commercial operations across 18 countries, and earlier held senior commercial roles at Johnson & Johnson, including president of Janssen Immunology North America. She earned a bachelor of science in pharmacy from the University of Manchester.
Roles
Agios Pharmaceuticals, Inc.
Director · Current role
Jun 2023–present
Bristol-Myers Squibb
SVP, Major Markets · Oversaw commercial operations across 18 countries; joined BMS in 2019.
—
Johnson & Johnson
President, Janssen Immunology North America
2018 – 2019
Johnson & Johnson
President, Infectious Diseases (US)
2016 – 2018
AstraZeneca
Production support pharmacist · Began pharmaceutical-industry career in 1992 in London.
—
External Roles
AssistRx
Director
—
Acadia Pharmaceuticals
Chief Executive Officer and Board of Directors
—
AssistRx
Board of Directors
—
Optinose PLC
Board of Directors and Chair of the Compensation Committee
—
Director Compensation
FY 2025Fees earned or paid in cash
$58,750
Fiscal year2025
Option awards
$299,689
Grant-date fair valueFASB ASC Topic 718
Stock awards
$99,968
Grant-date fair valueFASB ASC Topic 718
Total
$458,407
Also at Agios Pharmaceuticals, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.